B.S., Rockhurst College, Kansas City KS Ph.D., Duke University, Durham NC Postdoc, Karolinska Institute, Sweden Postdoc, Wayne State University, Detroit MI
850 Robinson Research Building
850 RRB 0146
cyclooxygenase, prostaglandins, antiinflammatory agent, endocannabinoids, DNA damage, mutagenesis, oxidative stress and cell signaling, apoptosis
Cyclooxygenase-2 structure and function; chemistry and biology of DNA damage-dependent mutagenesis and signaling
A major interest in the Marnett laboratory is the structure and function of cyclooxygenase-2 (COX-2). This enzyme catalyzes the committed step in the production of prostaglandins and is the molecular target for non-steroidal antiinflammatory drugs. Functional analysis of COX-2 by structure-guided mutagenesis has uncovered new strategies for synthesizing COX-2 inhibitors and has suggested new biological roles for the enzyme. Current work focuses on the generation of novel antiinflammatory drugs with additional pharmacological functions and on investigations of the chemistry and biology of COX-2-dependent oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins.
Another major interest in the Marnett laboratory is the chemistry and biology of DNA damage by endogenously generated products of oxidative stress. Individual products of DNA damage are incorporated into viral genomes for in vivo mutagenesis experiments. Similar experiments are used to identify human DNA repair enzymes that remove specific forms of DNA damage.
A new area of interest in the laboratory is the investigation of protein targets of drugs and toxic compounds and the consequences of protein modification in modulating biological function.
A broad range of techniques are used by the Marnett group including chemical synthesis, enzymology, protein expression, site-directed mutagenesis, bioanalytical chemistry, mass spectrometry, in vivo mutagenesis, tissue culture, proteomics, and techniques of signal transduction.
R.P. Remmel, B.C. Crews, K.R. Kozak, A.S. Kalgutkar, and L.J. Marnett. . Studies on the Metabolism of the Novel, Selective Cyclooxygenase-2 Inhibitor, Indomethacin Phenethylamide in Rat, Mouse, and Human Liver Microsomes: Identification of Active Metabolites. Drug Metab. Dispos., 32, 113-122, 2004
K.R. Kozak, J.J. Prusakiewicz, S.W. Rowlinson, C. Schneider, and L.J. Marnett.. Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonyl-glycerol. J. Biol. Chem, 276, 30072-30077, 2001